See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2014_GYRE_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 93,606,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 97,000 |
| 2 | PropertyPlantAndEquipmentNet | 682,000 |
| 3 | remainder_Assets | 51,488,000 |
| 4 | LiabilitiesCurrent | 10,979,000 |
| 5 | LiabilitiesNoncurrent | 283,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,005,000 |
| 9 | ResearchAndDevelopmentExpense | 38,840,000 |
| 10 | remainder_Expenses | 7,000 |
| 11 | remainder_Revenues | 3,629,000 |
| 12 | remainder_NetIncome | 518,000 |
| 13 | remainder_ComprehensiveNetIncome | -114,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 145,873,000 |
| 1 | Liabilities | 11,262,000 |
| 2 | Expenses | 50,852,000 |
| 3 | Revenues | 3,629,000 |
| 4 | StockholdersEquity | 134,611,000 |
| 5 | NetIncome | -46,705,000 |
| 6 | ComprehensiveNetIncome | -46,762,000 |
| 7 | BaseVar | 106,124,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.14 |
| 9 | EconomicCapitalRatio | 3.78 |
Edgar->Model Mapping
Feature Distribution
Change over Time
